Search results
Results from the WOW.Com Content Network
200 mg 1x/4–6 weeks Implant: Testosterone: Testopel: Pellet: 50–100 mg 1x/3–6 months Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per 4 weeks). Footnotes: a = Mostly discontinued or unavailable. b = Over-the-counter.
Testosterone levels in males and females ; Total testosterone Stage Age range Male Female Values SI units Values SI units ; Infant: Premature (26–28 weeks) 59–125 ng/dL: 2.047–4.337 nmol/L
Testosterone is a medication and naturally occurring steroid hormone. [9] It is used to treat male hypogonadism, gender dysphoria, and certain types of breast cancer. [9] [10] It may also be used to increase athletic ability in the form of doping. [9]
25–100 mg/day Injection (IM Tooltip intramuscular injection or SC Tooltip subcutaneous injection) Testosterone propionate: Oil solution: 50–100 mg 3x/week Testosterone enanthate: Oil solution: 200–400 mg 1x/2–4 weeks Testosterone cypionate: Oil solution: 200–400 mg 1x/2–4 weeks Mixed testosterone esters: Oil solution: 250 mg 1x/week ...
0.5–5 mg/day Various: Estrogen: SC implant: 50–200 mg every 6–24 mos Estradiol valerate: Progynova: Estrogen: Oral: 2–10 mg/day Progynova: Estrogen: Sublingual: 1–8 mg/day Delestrogen [c] Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks ...
Injection (IM Tooltip intramuscular injection or SC Tooltip subcutaneous injection) Testosterone: Andronaq, Sterotate, Virosterone: Aqueous suspension: 10–50 mg 2–3×/week Testosterone propionate b: Testoviron: Oil solution: 10–50 mg 2–3×/week Testosterone enanthate: Delatestryl: Oil solution: 50–250 mg 1x/1–4 weeks Xyosted: Auto ...
A study by Fung and colleagues (2017) found no difference in suppression of circulating testosterone levels (~95% suppression) in transgender women by the combination of either 25 mg/day oral CPA or 50 mg/day oral CPA with a moderate dosage of oral or transdermal estradiol (mean 3.3 mg/day oral, 3.4 g/day gel, or 95.6 μg/day patches).
Vosilasarm has been assessed in clinical trials in women with breast cancer at doses ranging from 50 to 150 mg/day, with the maximum safe and tolerated dose being 100 mg/day. [ 10 ] [ 3 ] [ 2 ] The drug sold via black-market Internet suppliers and used non-medically has been reported to be taken at doses of 5 to 30 mg/day, with unknown adverse ...